Log In
BCIQ
Print this Print this
 

AP-5258

  Manage Alerts
Collapse Summary General Information
Company Arteria S.A.
DescriptionCD36 (GPIV) inhibitor
Molecular Target CD36 (GPIV)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDyslipidemia
Indication DetailsTreat postprandial hypertriglyceridemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today